GLSI profile · all as-reported value updates
Greenwich LifeSciences, Inc. (GLSI) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2024 | 2,534,036 | 908,626 | -1,625,410 | -64.14% | revised comparative figure | 0001641172-25-004819 0001493152-26-026651 | 2 filed observations examined for this concept and period. |
| Liabilities | 2024 | 1,559,733 | 3,185,143 | 1,625,410 | +51.03% | revised comparative figure | 0001641172-25-004819 0001493152-26-026651 | 2 filed observations examined for this concept and period. |
| Net income | 2024 | -15,788,809 | -17,414,219 | -1,625,410 | -9.33% | revised comparative figure | 0001641172-25-004819 0001493152-26-026651 | 2 filed observations examined for this concept and period. |
| Operating income | 2024 | -16,011,817 | -17,637,227 | -1,625,410 | -9.22% | revised comparative figure | 0001641172-25-004819 0001493152-26-026651 | 2 filed observations examined for this concept and period. |